Abnormal activation of cytokine gene expression by intracisternal type A particle transposition: Effects of mutations that result in autocrine growth stimulation and malignant transformation

Cytokines, Cellular and Molecular Therapy

Volumn 3, Issue 1, 1997, Pages 3-19

  Wang, Xiao Yang ^a   Steelman, Linda S ^a   McCubrey, James A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

IAP autocrine transformation; IL 3; Transposition

Indexed keywords

CYTOKINE; INTERLEUKIN 3; MESSENGER RNA;

AUTOCRINE EFFECT; CANCER GENETICS; CARCINOGENESIS; CELL GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; DNA TRANSPOSITION; ELECTROPHORETIC MOBILITY; GENE EXPRESSION REGULATION; GENE LOCUS; GENE MUTATION; GENOME; GROWTH STIMULATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INTRACISTERNAL A TYPE PARTICLE; NORTHERN BLOTTING; ONCOGENE; PRIORITY JOURNAL; RETROVIRUS; REVIEW; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION;

ANIMALS; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; DEFECTIVE VIRUSES; DNA TRANSPOSABLE ELEMENTS; GENE EXPRESSION REGULATION; GENES, INTRACISTERNAL A-PARTICLE; HEMATOPOIESIS; HUMANS; INTERLEUKIN-3; MICE; MODELS, BIOLOGICAL; MUTATION; ONCOGENES; RECEPTORS, INTERLEUKIN-3; RETROVIRIDAE; RNA, MESSENGER;

EID: 0030854135     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (153)

1. Arai K-I, Lee F, Miyajima A et al, Cytokines: coordinations of immune and inflammatory responses. Annu Rev Biochem (1990) 59: 783-836.
2. Van den Brink MRM, Boggs SS, Herberman RB, Hiserodt JC, The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures. J Exp Med (1990) 172: 303-13.
3. Avraham H, Vannier E, Cowley S et al, Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood (1992) 79: 365-71.
4. Ayroldi E, Cannarile L, D'Adamio F et al, Long-term cultures of mouse bone marrow cells: a model for studying the generation of natural killer cells. Nat Immun (1992) 11: 317-27.
5. Guba SC, Sartor CI, Gottschalk LR et al, Bone marrow stromal fibroblasts secrete interleukin-6 and granulocyte-macrophage colony-stimulating factor in the absence of inflammatory stimulation: demonstration by serum-free bioassy, enzyme-linked immunosorbent assay, and reverse transcriptase polymerase chain reaction. Blood (1992) 80: 1190-8.
6. Quesniaux VFJ, Clark SC, Turner K, Fagg B, Interleukin-11 stimulates multiple phases of erythropoiesis in vitro. Blood (1992) 80: 1218-23.
7. Quesniaux VF, Interleukin-11. Leuk Lymphoma (1994) 14: 241-9.
8. Heinrich MC, Dooley DC, Freed AC et al, Constitutive expression of steel factor gene by human stromal cells. Blood (1993)82: 771-83.
9. Hoffman R, Tong J, Brandt J et al, The in vitro and in vivo effects of stem cell factor on human hematopoiesis. Stem Cells (1993) 11 (Suppl 2): 76-82.
10. Pollack SB, Production and differentiation of NK linkeage cells in bone marrow. Nat Immun (1993) 12: 177-93.
11. Pollack SB, Tsuji J, Effects of rIL-7 on murine bone marrow NK precursor cells. Cell Immunol (1993) 151: 1-11.
12. Bellone G, Trinchieri G, Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis. J Immunol (1994) 153: 930-7.
13. Carson WE, Giri JG, Lindemann MJ et al, Interleukin (IL) 15 is a novel cytokine that activated human natural killer cells via components of the IL-2 receptor. J Exp Med (1994) 180: 1395-403.
14. Cavaillon JM, Cytokines and macrophages. Biomed Pharmacother (1994) 48: 445-53.
15. Kawano Y, Takaue Y, Hirao A et al, Synergy among erythropoietin, interleukin 3, stem cell factor (c-kit ligand) and interferon-gamma on early human hematopoiesis. Stem Cells (1994) 12: 514-20.
16. Kuby J, Immunology, 2nd edn. Freeman, New York, 1994.
17. Zeigler FC, Bennett BD, Jordan CT et al, Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells. Blood (1994) 84: 2422-30.
18. Armitage RJ, Macduff BM, Eisenman J et al, IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol (1995) 154: 483-90.
19. Banu N, Wang JF, Deng BJ et al, Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand. Blood (1995) 86: 1331-8.
20. Cluitmans FHM, Esendam BHJ, Landegent JE et al, Constitutive in vivo cytokine and hematopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals. Blood (1995) 85: 2038-44.
21. Galy A, Travis M, Cen D, Chen B, Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity (1995) 3: 459-73.
22. Hirao A, Takaue Y, Kawano Y et al, Synergism of interleukin 12, interleukin 3 and serum factor on primitive human hematopoietic progenitor cells. Stem Cells (1995) 13: 47-53.
23. Hirayama F, Lyman SD, Clark SC, Ogawa M, The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood (1995) 85: 1762-8.
24. Jackson JD, Yan Y, Brunda MJ et al, Interleukin-12 enhances peripheral hematopoiesis in vivo. Blood (1995) 85: 2371-6.
25. Kaushansky K, Broudy VC, Lin N et al, Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA (1995) 92: 3234-8.
26. + cells purified from cord blood and fetal liver. Exp Hematol (1995) 23: 422-7.
27. + hematopoietic progenitor cells. Blood (1995) 86: 3413-20.
28. Muench MO, Roncarolo MG, Menon S et al, FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood (1995) 85: 963-72.
29. Schmitt C, Ktorza S, Sarun S et al, CD34-positive early stages of human T-cell differentiation. Leuk Lymphoma (1995) 17: 43-50.
30. + hematopoietic progenitor cells. Blood (1995) 85: 3538-46.
31. Brashem-Stein C, Flowers DA, Bernstein ID, Regulation of colony forming cell generation by flt-3 ligand. Br J Haematol (1996) 94: 17-22.
32. Lisovsky M, Braun SE, Ge Y et al, Flt3-ligand production by human bone marrow stromal cells. Leukemia (1996) 10: 1012-8.
33. + hematopoietic progenitor cells. Blood (1996) 87: 2632-40.
34. dim cells in the human thymus can differentiate into T, natural killer, and dendritic cells but are distinct from pluripotent stem cells. Blood (1996) 87: 5196-206.
35. Sitnicka E, Lin N, Priestley GV et al, The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood (1996) 87: 4998-5005.
36. Snoeck H-W, Weekx S, Moulijn A et al, Tumor necrosis factor α is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor β but not to interferon γ. J Exp Med (1996) 183: 705-10.
37. Nicola NA, Vadas M, Hemopoietic colony-stimulating factors. Immunol Today (1984) 5: 76-80.
38. Dexter TM, Moore M, Growth and developemt in the haemopoietic system: the role of lymphokines and their possible therapeutic potential in disease and malignancy. Carcinogenesis (1986) 7: 509-16.
39. Metcalf D, The granulocyte-macrophage colony-stimulating factors. Science (1985) 229: 16-22.
40. Sachs L, The molecular control of blood cell development. Science (1987) 238: 1374-9.
41. Cross M, Dexter TM, Growth factors in developemt, transformation, and tumorigenesis. Cell (1991) 64: 271-80.
42. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM, Suppression of apoptosis allows differentiation and development of a multipotential hemopoietic cell line in the absence of added growth factors. Cell (1993) 74: 823-32.
43. Cook WD, Metcalf D, Nicola NA et al, Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell (1985) 41: 677-83.
44. Pierce JH, Di Fiore PP, Aaronson SA et al, Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell (1985) 41: 685-3.
45. Mathey-Prevot B, Nabel G, Palacios R, Baltimore D, Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line. Mol Cell Biol (1986) 6: 4133-5.
46. Rovera G, Valtieri M, Mavilio F, Reddy EP, Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line. Oncogene (1987) 1: 29-35.
47. Kipreos ET, Wang JY, Reversible dependence on growth factor interleukin-3 in myeloid cells expressing temperature sensitive v-abl oncogene. Oncogene Res (1988) 2: 277-84.
48. McCubrey JA, Holland G, McKearn J, Risser R, Abrogation of factor-dependence in two IL-3-dependent cell lines can occur by two distinct mechanisms. Oncogene Res (1989) 4: 97-109.
49. Pierce JH, Ruggiero M, Fleming TP et al, Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. Science (1988) 239: 628-31.
50. Wheeler EF, Askew D, May S et al, The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1. Mol Cell Biol (1987) 7: 1673-80.
51. Overell RW, Watson JD, Gallis B et al, Nature and specificity of lymphokine independence induced by a selectable retroviral vector expressing v-src. Mol Cell Biol (1987) 7: 3394-401.
52. McCubrey JA, Smith SR, Algate PA et al, Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene. Oncogene (1993) 8: 2905-15.
53. Meckling-Gill KA, Yee SP, Schrader JW, Pawson T, A retrovirus encoding the v-fps protein-tyrosine kinase induces factor-independent growth and tumorigenicity in FDC-P1 cells. Biochim Biophys Acta (1992) 1137: 65-72.
54. Cleveland JL, Troppmair J, Packham G et al, v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. Oncogene (1994) 9: 2217-26.
55. McCubrey JA, Steelman LS, Wang X-Y et al, Differential effects of viral and cellular oncogenes on the growth factor-dependency of hematopoietic cells. Int J Oncol (1995) 7: 295-310.
56. Uemura N, Ozawa K, Tojo A et al, Acquisition of interleukin-3 independence in FDC-P2 cells after transfection with the activated c-H-ras gene using a bovine papillomavirus-based plasmid vector. Blood (1992) 80: 3198-204.
57. McCubrey JA, Steelman LS, Viral models for understanding chronic myelogenous leukemia. In: Hematology, Vol 13: Chronic Myelogenous Leukemia (ed AB Deisseroth, RB Arlinghaus) 137-52. Marcel Dekker, New York, 1991.
58. Cohen A, Grunberger T, Vanek W et al, Constitutive expression and role in growth regulation of interleukin-1 and multiple cytokine receptors in a biphenotypic leukemic cell line. Blood (1991) 78: 94-102.
59. Estrov Z, Kurzrock R, Estey E et al, Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. Blood (1992) 79: 1938-45.
60. Attias D, Grunberger T, Vanek W et al, B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts. Leukemia (1995) 9: 884-8.
61. X and T3/Ti complex triggering. Cell (1987) 48: 343-50.
62. Grimaldi JC, Meeker TC, The t(5; 14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene. Blood (1989) 73: 2081-5.
63. Meeker TC, Hardy D, William C et al, Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood (1990) 76: 285-9.
64. Kawano M, Hirano T, Matsuda T et al, Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature (1988) 332: 83-5.
65. Westendorf JJ, Ahmann GJ, Greipp PR et al, Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6. Leukemia (1996) 10: 866-76.
66. Touw J, Pouwels K, van Agthoven T et al, Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. Blood (1990) 75: 2097-101.
67. Francia di Celle P, Mariani S, Riera L et al, Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood (1996) 87: 4382-9.
68. Flubacher MM, Bear SE, Tsichlis PN, Replacement of interleukin-2 (IL-2)-generated mitogenic signals by a mink cell focus-forming (MCF) or xenotropic virus-induced IL-9-dependent autocrine loop: implications for MCF virus-induced leukemogenesis. J Virol (1994) 68: 7709-16.
69. +B (B-1) cells by antisense IL-10 oligonucleotide. Leukemia Res (1995) 19: 159-67.
70. Kobayashi S, Teramura M, Sugawara I et al, Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines. Blood (1993) 81: 889-93.
71. Villeval J-L, Mitjavila MT, Dusanter-Fourt I et al, Autocrine stimulation by erythropoietin (Epo) requires Epo secretion. Blood (1994) 84: 2649-62.
72. Krystal GW, Hines SJ, Organ CP, Autocrine growth of small cell lung cancer mediated by expression of c-kit and stem cell factor. Cancer Res (1996) 56: 370-6.
73. Rettenmier CW, Roussel MF, Ashmun RA et al, Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes. Mol Cell Biol (1987) 7: 2378-87.
74. Young DC, Griffin JD, Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood (1986) 68: 1178-81.
75. Freedman MH, Grunberger T, Correa P et al, Autocrine and paracrine growth control by granulocyte-monocyte colony-stimulating factor of acute lymphoblastic leukemia cells. Blood (1993) 81: 3068-75.
76. Estrov Z, Talpaz M, Ku S et al, Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF. Leukemia (1996) 10: 1534-43.
77. Wright JA, Turley EA, Greenberg AH, Transforming growth factor β and fibroblst growth factor as promoters of tumor progression to malignancy. Crit Rev Oncogenesis (1993) 4: 473-92.
78. Estrov Z, Kurzrock R, Pocsik E et al, Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. J Exp Med (1993) 177: 763-74.
79. Gibbons DL, Rowe M, Cope AP et al, Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Eur J Immunol (1994) 24: 1879-85.
80. Potapova O, Fakhrai H, Baird S, Mercola D, Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells. Cancer Res (1996)56: 280-6.
81. Potapova O, Fakhrai H, Mercola D, Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism. Int J Cancer (1996) 66: 669-77.
82. Ciardiello F, Bianco C, Normanno N et al, Infection with a transforming growth factor a anti-sense retroviral expression vector reduces the in vitro growth and transformation of a human colon cancer cell line. Int J Cancer (1993) 54: 952-8.
83. Sherwood ER, Lee C, Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate. World J Urol (1995) 13: 290-6.
84. Balkwill FR, Burke F, The cytokine network. Immunol Today (1989) 10: 299-304.
85. Ethier SP, Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst (1995) 87: 964-73.
86. Nicolson GL, Menter DG, Herrmann J et al, Tumor metastasis to brain: role of endothelial cells, neurotrophins, and paracrine growth factors. Crit Rev Oncogenesis (1994) 5: 451-71.
87. Cook RM, Miller YE, Bunn PAJ, Small cell lung cancer: etiology, biology, clinical features, staging, and treatment. Curr Prob Cancer (1993) 17: 69-141.
88. Moody TW, Cuttitta F, Growth factor and peptide receptors in small cell lung cancer. Life Sci (1993) 52: 1161-73.
89. Algate PA, Steelman LS, Mayo MW et al, Regulation of the interleukin-3 (IL-3) receptor by IL-3 in the fetal liver-derived FL5.12 cell line. Blood (1994) 83: 2459-68.
90. Steelman LS, Algate PA, Blalock WL et al, Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells. Leukemia (1996) 10: 528-42.
91. Dexter TM, Garland J, Scott D et al, Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med (1980) 152: 1036-47.
92. Greenberger JS, Sakakeeny MA, Humphries RK et al, Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA (1983) 80: 2931-5.
93. Palacios R, Henson G, Steinmetz M, McKearn JP, Interleukin-3 supports growth of mouse pre-B-cell clones in vitro. Nature (1984) 309: 126-31.
94. McKearn JP, McCubrey JA, Fagg B, Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors. Proc Natl Acad Sci USA (1985) 82: 7414-8.
95. McCubrey JA, Steelman LS, Risser RG, McKearn JP, Structure and expression of the T cell receptor γ locus in pre-B and early hemopoietic cells. Eur J Immunol (1989) 19: 2303-8.
96. Algate PA, McCubrey JA, Autocrine transformation of hemopoietic cells resulting from cytokine message stabilization after intracisternal A particle transposition. Oncogene (1993) 8: 1221-32.
97. Kuff EL, Lueders KK, The intracisternal A-particle gene family: structure and functional aspects. Adv Cancer Res (1988) 51: 183-276.
98. Kuff EL, Fewell JW, Intracisternal A-particle gene expression in normal mouse thymus tissue: gene products and strain-related variability. Mol Cell Biol (1985)5: 474-83.
99. Dupressoir A, Heidmann T, Germ line-specific expression of intracisternal A-particle retrotransposons in transgenic mice. Mol Cell Biol (1996) 16: 4495-503.
100. Leiter EH, Kuff EL, Immunocytochemical demonstration of increased antigen (p73) in genetically diabetic mice. Am J Pathol (1984) 114: 46-55.
101. Chang-Yeh A, Mold DE, Huang RCC, Identification of a novel murine IAP-promoted placenta-expressed gene. Nucl Acids Res (1991) 19: 3667-72.
102. Shen-Ong GLC, Cole MD, Differing populations of intracisternal A-particle genes in myeloma tumors and mouse subspecies. J Virol (1982) 42: 411-21.
103. Briggs MR, Kadonaga JT, Bell SP, Tjian R, Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science (1986) 234: 47-52.
104. Lamb BT, Satymoorthy K, Li L et al, CpG methylation of an endogenous retroviral enhancer inhibits transcription factor binding and activity. Gene Expression (1991) 1: 185-96.
105. Satyamoorthy K, Park K, Atchison ML, Howe CC, The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements. Mol Cell Biol (1993) 13: 6621-8.
106. Scheidereit C, Beato M, Contacts between hormone receptor and DNA double helix within a glucocorticoid regulatory element of mouse mammary tumor virus. Proc Natl Acad Sci USA (1984) 81: 3029-33.
107. Tsai SY, Carlstedt-Duke J, Weigel NL et al, Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell (1988) 55: 361-9.
108. Weiher H, Konig M, Gruss P, Multiple point mutations affecting the simian virus 40 enhancer. Science (1983) 219: 626-31.
109. Landschulz WH, Johnson PF, Adashi EY et al, Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev (1988) 2: 786-800.
110. Falzon M, Kuff EL, Isolation and characterization of a protein fraction that binds to enhancer core sequences in intracisternal A-particle long terminal repeats. J Biol Chem (1989) 264: 21 915-22.
111. Falzon M, Kuff EL, Binding of the transcription factor EBP-80 mediates the methylation response of an intracisternal A-particle long terminal repeat promoter. Mol Cell Biol (1991) 11: 117-25.
112. Montminy MR, Sevarino KA, Wagner JA et al, Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Proc Natl Acad Sci USA (1986) 83: 6682-6.
113. Lin Y-S, Green MR, Interaction of a common cellular transcription factor, ATF, with regulatory elements in both E1a- and cyclic AMP-inducible promoters. Proc Natl Acad Sci USA (1988) 85: 3396-400.
114. Montminy MR, Bilezikjian LM, Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature (1987) 328: 175-8.
115. Jones KA, Kadonago JT, Rosenfeld PJ et al, A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell (1987) 48: 79-89.
116. Kamat JP, Basu A, Satyamoorthy K et al, IPEB transcription factor regulating the intracisternal A particle gene during F9 cell differentiation is expressed at sites of lymphoid development. Mol Reprod Dev (1995) 41: 8-15.
117. Lueders KK, Fewell JW, Morozov VE, Kuff EL, Selective expression of intracisternal A-particle genes in established mouse plasmacytomas. Mol Cell Biol (1993) 13: 7439-46.
118. Keshet E, Schiff R, Itin A, Mouse retrotransposons: a cellular reservoir of long terminal repeat (LTR) elements with diverse transcriptional specificities. Adv Cancer Res (1991) 56: 215-51.
119. Hawley RG, Shulman MJ, Hozumi N, Transposition of two different intracisternal A particle elements into an immunoglobulin kappa-chain gene. Mol Cell Biol (1984) 4: 2565-72.
120. Adachi M, Watanabe-Fukunaga R, Nagata S, Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA (1993) 90: 1756-60.
121. Chu J-L, Drappa J, Parnassa A, Elkon KB, The defect in Fas mRNA expression in MRL/Zpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med (1993) 178: 723-30.
122. Wu J-G, Zhou T, He J, Mountz JD, Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med (1993) 178: 461-8.
123. Rechavi G, Givol D, Canaani E, Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element. Nature (1982) 300: 607-11.
124. Cohen JB, Unger T, Rechavi G et al, Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas. Nature (1983) 306: 797-9.
125. Horowitz M, Luria S, Rechavi G, Givol D, Mechanism of activation of the mouse c-mos oncogene by the LTR of an intracisternal A-particle gene. EMBO J (1984) 3: 2937-41.
126. Ymer S, Tucker WQJ, Sanderson CJ et al, Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene. Nature (1985) 317: 255-8.
127. Blatt C, Aberdam D, Schwartz R, Sachs L, DNA rearrangement of a homeobox gene in myeloid leukaemic cells. EMBO J (1988) 7: 4283-90.
128. Kongsuwan K, Allen J, Adams JM, Expression of Hox-2.4 homeobox gene directed by proviral insertion in a myeloid leukemia. Nucl Acids Res (1989) 17: 1881-92.
129. Baumruker T, Gehe C, Horak I, Insertion of a retrotransposon within the 3′ end of a mouse gene provides a new functional polyadenylation signal. Nucl Acid Res (1988) 16: 7241-51.
130. Stocking C, Loliger C, Kawai M et al, Identification of genes involved in growth autonomy of hematopoietic cells by analysis of factor-independent mutants. Cell (1988) 53: 869-79.
131. Duhrsen U, Stahl J, Gough NM, In vivo transformation of factor-dependent hemopoietic cells: role of intracisternal A-particle transposition for growth factor gene activation. EMBO J (1990) 9: 1087-96.
132. Leslie KB, Lee F, Schrader JW, Intracisternal A-type particle-mediated activation of cytokine genes in a murine myelomonocytic leukemia: generation of functional cytokine mRNAs by retroviral splicing events. Mol Cell Biol (1991) 11: 5562-70.
133. Tohyama K, Lee KH, Tashiro K et al, Establishment of an interleukin-5-dependent subclone from an interleukin-3-dependent murine hemopoietic progenitor cell line, LyD9, and its malignant transformation by autocrine secretion of interleukin-5. EMBO J (1990) 9: 1823-30.
134. Blankenstein T, Qin ZH, Li WQ, Diamantstein T, DNA rearrangement and constitutive expression of the interleukin 6 gene in a mouse plasmacytoma. J Exp Med (1990) 171: 965-70.
135. Kono T, Doi T, Yamada G et al, Murine interleukin 2 receptor β chain: dysregulated gene expression in lymphoma line EL-4 caused by a promoter insertion. Proc Natl Acad Sci USA (1990) 87: 1806-10.
136. Sugita T, Totsuka T, Saito M et al, Functional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain. Its possible role in plasmacytomagenesis. J Exp Med (1990) 171: 2001-9.
137. Canaani E, Dreazen O, Klar A et al, Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome. Proc Natl Acad Sci USA (1983) 80: 7118-22.
138. Connelly MA, Grady RC, Mushinski JF, Marcu KB, PANG, a gene encoding a neuronal glycoprotein, is ectopically activated by intracisternal A-type particle long terminal repeats in murine plasmcytomas. Proc Natl Acad Sci USA (1994) 91: 1337-41.
139. Malstrom CE, Kotsenas AL, Jones B, Interaction of H-2Eb with an IAP retrotransposon in the A20/2J B cell lymphoma. Immunogenetics (1992) 36: 238-47.
140. Brigle KE, Westin EH, Houghton MT, Goldman ID, Insertion of an intracisternal A particle within the 5′-regulatory region of a gene encoding folate-binding protein in L1210 leukemia cells in response to low folate selection. J Biol Chem (1992) 267: 22 351-5.
141. Mayo MW, Wang X-Y, Algate PA et al, Synergy between AUUUA motif disruption and enhancer insertion results in autocrine transformation of interleukin-3-dependent hematopoietic cells. Blood (1995) 86: 3139-50.
142. Wang X-Y, McCubrey JA, Malignant transformation induced by cytokine genes: a comparison of the abilities of germline and mutated interleukin 3 genes to transform hematopoietic cells by transcriptional and posttranscriptional mechanisms. Cell Growth Differ (1996) 7: 487-500.
143. Mathey-Prevot B, Andrews NC, Murphy HS et al, Positive and negative elements regulate human interleukin 3 expression. Proc Natl Acad Sci USA (1990) 87: 5046-50.
144. Shoemaker SG, Hromas R, Kaushansky K, Transcriptional regulation of interleukin 3 gene expression in T lymphocytes. Proc Natl Acad Sci USA (1990) 87: 9650-4.
145. Davies K, TePas EC, Nathan DG, Mathey-Prevot B, Interleukin-3 expression by activated T cells involves an inducible, T-cell-specific factor and an octamer binding protein. Blood (1993) 81: 928-34.
146. Wang X-Y, McCubrey JA, Differential effects of retroviral long terminal repeats on interleukin 3 gene expression and autocrine transformation. Int J Oncol (1997) in press.
147. Shaw G, Kamen R, A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell (1986) 46: 659-67.
148. Stoecklin G, Hahn S, Moroni C, Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. J Biol Chem (1994) 269: 28 591-7.
149. Wang X-Y, McCubrey JA, Proteins binding specifically to the interleukin 3 mRNA 3′ untranslated region. Submitted to J Biol Chem (1997).
150. Hirsch HH, Nair APK, Moroni C, Suppressible and nonsuppressible autocrine mast cell tumors are distinguished by insertion of an endogenous retroviral element (TAP) into the interleukin 3 gene. J Exp Med (1993) 178: 403-11.
151. Kazazian HHJ, Wong C, Youssoufian H et al, Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature (1988) 332: 164-6.
152. Wallace MR, Andersen LB, Saulino AM et al, A de novo Alu insertion results in neurofibromatosis type 1. Nature (1991) 353: 864-6.
153. Muratani K, Hada T, Yamamoto Y et al, Inactivation of the cholinesterase gene by Alu insertion: possible mechanism for human gene transposition. Proc Natl Acad Sci USA (1991) 88: 11 315-9.